All Product News

East Windsor, N.J. – Aurobindo Pharma Limited has received final approval from U.S. Food and Drug Administration for its Abbreviated New Drug Application Chlordiazepoxide Hydrochloride and Clidinium Bromide Capsules USP, 5 mg/2.5 mg. Aurobindo Pharma’s Chlordiazepoxide Hydrochloride and Clidinium Bromide Capsules, are an AB-rated generic equivalent to the reference listed drug (RLD), Librax® Capsules manufactured […]

East Windsor, N.J. – Aurobindo Pharma Limited has received final approval from U.S. Food and Drug Administration for its Abbreviated New Drug Application Loperamide Hydrochloride Capsules USP, 2mg. Aurobindo Pharma’s Loperamide Hydrochloride Capsules are an AB-rated generic equivalent to the reference listed drug (RLD),  Imodium® Capsules, manufactured by Johnson and Johnson Consumer Inc., McNeil Consumer Healthcare Division. Loperamide Hydrochloride […]

East Windsor, N.J. – Aurobindo Pharma Limited has received final approval from U.S. Food and Drug Administration for its Abbreviated New Drug Application Fluphenazine Hydrochloride Tablets 1mg, 2.5mg, 5mg, and 10mg. Aurobindo Pharma’s Fluphenazine Hydrochloride Tablets are an AB-rated generic equivalent to the reference listed drug (RLD), Prolixin Tablets manufactured by Apothecon Inc. Fluphenazine Hydrochloride Tablets are indicated for : […]

East Windsor, N.J. – Aurobindo Pharma Limited has received final approval from U.S. Food and Drug Administration for its Abbreviated New Drug Application Saxagliptin Tablets. Aurobindo Pharma’s Saxagliptin Tablets are an are an AB-rated generic equivalent to the reference listed drug (RLD),Onglyza Tablets, manufactured by AstraZeneca AB. Saxagliptin Tablets, are indicated for : An adjunct […]

East Windsor, N.J. – Aurobindo Pharma Limited has received final approval from U.S. Food and Drug Administration for its Abbreviated New Drug Application Hydrocortisone Tablets USP, 5 mg, 10 mg, and 20 mg. Aurobindo Pharma’s Hydrocortisone Tablets, are an AB-rated generic equivalent to the reference listed drug (RLD), CORTEF® tablets manufactured by Pharmacia and Upjohn […]

East Windsor, N.J. – Aurobindo Pharma Limited has received final approval from U.S. Food and Drug Administration for its Abbreviated New Drug Application Ertugliflozin Tablets, 5 mg and 15 mg. Aurobindo Pharma’s Ertugliflozin Tablets, are an AB-rated generic equivalent to the reference listed drug (RLD), STEGLATRO® Tablets manufactured by Merck Sharp & Dohme LLC (Merck). […]

East Windsor, N.J. – Aurobindo Pharma Limited has received final approval from U.S. Food and Drug Administration for its Abbreviated New Drug Application for Aurobindo Receives FDA Approval Ramelteon Tablets, are an AB-rated generic equivalent to the reference listed drug (RLD), ROZEREM® Tablets manufactured by Takeda Pharmaceuticals USA Inc. Ramelteon Tablets, are indicated for : Treatment of […]

East Windsor, N.J. – Aurobindo Pharma Limited has received final approval from U.S. Food and Drug Administration for its Abbreviated New Drug Application Sevelamer Hydrochloride Tablets 400 mg and 800 mg. Aurobindo Pharma’s Sevelamer Hydrochloride Tablets, are an AB-rated generic equivalent to the reference listed drug (RLD), RENAGEL® Tablets manufactured by Genzyme Corporation. Sevelamer Hydrochloride […]

East Windsor, N.J. – Aurobindo Pharma Limited has received final approval from U.S. Food and Drug Administration for its Abbreviated New Drug Application Etyqa (Estradiol and Norethindrone Acetate Tablets USP), 0.5 mg/0.1 mg and 1 mg/0.5 mg. Aurobindo Pharma’s Etyqa (Estradiol and Norethindrone Acetate Tablets USP), are an AB-rated generic equivalent to the reference listed […]

East Windsor, N.J. – Aurobindo Pharma Limited has received final approval from U.S. Food and Drug Administration for its Abbreviated New Drug Application Rufinamide Tablets USP, 200mg and 400mg. Aurobindo Pharma’s Rufinamide Tablets, are an AB-rated generic equivalent to the reference listed drug (RLD), Banzel® Tablets, manufactured by Eisai Inc. Rufinamide Tablets, are indicated for: […]

East Windsor, N.J. – Aurobindo Pharma Limited has received final approval from U.S. Food and Drug Administration for its Abbreviated New Drug Application Apixaban Tablets, 2.5 mg and 5 mg. Aurobindo Pharma’s Apixaban Tablets, are an AB-rated generic equivalent to the reference listed drug (RLD), Eliquis Tablets manufactured by Bristol-Myers Squibb Company. Apixaban Tablets are […]

East Windsor, N.J. – Aurobindo Pharma Limited has received final approval from U.S. Food and Drug Administration for its Abbreviated New Drug Application for Prednisolone Tablets USP, 5mg. Aurobindo Pharma’s Prednisolone Tablets, are an AB-rated generic equivalent to the reference listed drug (RLD), Prednisolone (MillipredTM) Tablets USP, manufactured by Watson Laboratories Inc. Prednisolone Tablets, are indicated in the following […]